Search Results - Taio Naniwa

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Long-term effectiveness and safety of methotrexate-tacrolimus combination therapy versus methotrexate monotherapy in reducing rheumatoid arthritis flares after TNF inhibitor discon... by Taio Naniwa, Mikiko Kajiura

    Published in BMC Rheumatology (2025-04-01)
    Get full text
    Article


  2. 2

    Improvement of Arterial Wall Lesions in Parallel with Decrease of Plasma Pentraxin-3 Levels in a Patient with Refractory Takayasu Arteritis after Treatment with Tocilizumab by Shiho Iwagaitsu, Taio Naniwa

    Published in Case Reports in Rheumatology (2017-01-01)
    Get full text
    Article


  3. 3

    Successful Use of Higher-Dose Etanercept for Multirefractory Systemic Flare of Adult-Onset Still’s Disease with Liver Failure with No Response to Tocilizumab Therapy by Taio Naniwa, Shinya Tamechika, Shiho Iwagaitsu, Shinji Maeda, Hiroyuki Togawa

    Published in Case Reports in Rheumatology (2013-01-01)
    Get full text
    Article


  4. 4

    Improvement of Chronic Rhinosinusitis and Reduction of the Myeloperoxidase-Antineutrophil Cytoplasmic Antibody Titer in a Patient with Eosinophilic Granulomatosis with Polyangiitis... by Shin-ya Tamechika, Shuntaro Isogai, Shinji Maeda, Taio Naniwa, Akio Niimi

    Published in Case Reports in Rheumatology (2021-01-01)
    Get full text
    Article


  5. 5

    Comprehensive and advanced T cell cluster analysis for discriminating seropositive and seronegative rheumatoid arthritis by Shinji Maeda, Hiroya Hashimoto, Tomoyo Maeda, Shin-ya Tamechika, Taio Naniwa, Akio Niimi

    Published in Frontiers in Immunology (2025-07-01)
    Get full text
    Article


  6. 6

    High-dimensional analysis of T-cell profiling variations following belimumab treatment in systemic lupus erythematosus by Hiroya Hashimoto, Akio Niimi, Shinji Maeda, Tomoyo Maeda, Shin-ya Tamechika, Shuntaro Isogai, Taio Naniwa

    Published in Lupus Science and Medicine (2023-08-01)
    Get full text
    Article


  7. 7

    WITHDRAWN: Ten-year follow-up of patients with refractory systemic juvenile idiopathic arthritis after the clinical trial of tocilizumab as a first biologic disease-modifying antir... by Takako Miyamae, Kenichi Nishimura, Tomoyuki Imagawa, Eisuke Inoue, Seira Hattori, Tomonori Ishii, Shuichi Ito, Naomi Iwata, Yasuyuki Kamata, Yuji Kamiyama, Utako Kaneko, Mao Mizuta, Masaaki Mori, Ayako Murase, Yasuo Nakagishi, Naoko Nakano, Taiji Nakano, Shingo Nakayamada, Taio Naniwa, Tomo Nozawa, Takashi Ohya, Nami Okamoto, Kojiro Sato, Yuko Sugita, Syuji Takei, Seiji Tanaka, Yoshiya Tanaka, Minako Tomiita, Hiroaki Umebayashi, Yuichi Yamasaki, Norihiro Nishimoto, Shumpei Yokota

    Published in EULAR Rheumatology Open (2026-06-01)
    Get full text
    Article


Search Tools: